Skip to main content
KEQU
NASDAQ Industrial Applications And Services

Kewaunee Scientific Reports Mixed Q3 Results, Repays $23M Seller Notes, Boosts Operating Cash Flow

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$35.34
Mkt Cap
$101.298M
52W Low
$30.33
52W High
$60.891
Market data snapshot near publication time

summarizeSummary

Kewaunee Scientific reported a decline in Q3 net earnings but a significant increase in nine-month operating cash flow and successfully repaid $23.0 million in seller notes, improving its debt structure. The order backlog, however, decreased year-over-year.


check_boxKey Events

  • Q3 Net Earnings Decline

    Net earnings attributable to Kewaunee Scientific Corporation fell by 48.9% to $0.692 million ($0.23 diluted EPS) for the three months ended January 31, 2026, compared to $1.354 million ($0.45 diluted EPS) in the prior year period.

  • Strong Operating Cash Flow Growth

    Net cash provided by operating activities for the nine months ended January 31, 2026, significantly increased to $13.173 million, up from $5.376 million in the comparable prior year period.

  • Substantial Seller Note Repayment

    The company fully repaid $23.0 million in subordinated seller notes on December 4, 2025, funded by a new $10.0 million term loan and available revolving credit, significantly reducing total liabilities and long-term debt.

  • Decreased Order Backlog

    The order backlog stood at $183.2 million as of January 31, 2026, a decrease from $221.6 million at January 31, 2025.


auto_awesomeAnalysis

Kewaunee Scientific reported a significant year-over-year decline in Q3 net earnings and diluted EPS, which is a negative signal. However, the company demonstrated strong operational cash generation for the nine-month period, more than doubling cash provided by operating activities. A key positive development is the full repayment of $23.0 million in subordinated seller notes, a substantial reduction in long-term debt, which was partially funded by a new $10.0 million term loan. This debt restructuring improves the company's financial flexibility and reduces interest expense. The declining order backlog, previously reported, remains a concern for future revenue growth, indicating potential headwinds despite the strategic benefits from the Nu Aire acquisition.

At the time of this filing, KEQU was trading at $35.34 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $101.3M. The 52-week trading range was $30.33 to $60.89. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed KEQU - Latest Insights

KEQU
Mar 13, 2026, 11:31 AM EDT
Filing Type: 10-Q
Importance Score:
7
KEQU
Mar 11, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
KEQU
Mar 11, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
9